July 31, 2021 08:44 PM ISTThe company after consultation with merchant bankers will disclose the details about price band and lot size of IPO in the coming week.
July 31, 2021 04:09 PM IST Ravi Kant Jaipuria, Varun Jaipuria, and RJ Corp are the promoters of the company, having 75.79 percent shareholding as of now.
July 31, 2021 12:12 PM IST Krsnaa Diagnostics IPO will be among four public issues to open on August 4 along with Devyani International, Windlas Biotech, and Exxaro Tiles.
July 30, 2021 11:36 AM IST Investors have put in bids for 74.15 crore equity shares against offer size of 56.85 lakh equity shares, the subscription data available on exchanges showed.
July 30, 2021 08:32 AM IST Exxaro Tiles IPO: The company will utilise the net proceeds from fresh issue for repaying debt (Rs 50 crore), and working capital requirements (Rs 45 crore).
July 30, 2021 08:18 AM IST Devyani International IPO: Investors seem to be more excited about the issue, especially after the great success of IPOs of Zomato and Barbeque Nation Hospitality.
July 29, 2021 06:15 PM IST The net proceeds from its fresh issue will be utilised for repaying of debt (Rs 50 crore), and working capital requirements (Rs 45 crore).
July 29, 2021 11:53 AM IST Rolex Rings IPO has, so far, received bids for 2.87 crore equity shares against an initial public offering size of 56.85 lakh equity shares
July 29, 2021 11:39 AM IST Glenmark Life Science IPO and Rolex Rings IPO are two issues open for subscription currently. Analysts seem to be in favour of former owing to its place in the active pharmaceutical ingredients (API) business
July 29, 2021 11:29 AM IST Glenmark Life is planning to raise Rs 1,513.6 crore through its IPO, which comprises a fresh issue for Rs 1,060 crore and an offer for sale of 63 lakh equity shares by Glenmark Pharma
July 29, 2021 08:10 AM IST Windlas Biotech IPO: Promoter Vimla Windlass will sell 11.36 lakh equity shares, and investor Tano India Private Equity Fund II will offload its entire stake of 40,06,067 equity shares (or 22 percent of pre-offer paid up equity) via offer for sale.
July 28, 2021 06:55 PM IST The company will separately announce price band and lot size for its IPO in coming few days. The issue will close on August 6.
July 28, 2021 01:12 PM IST The price band for the offer could be disclosed separately by the company in coming days. The issue will close on August 6.
July 28, 2021 12:29 PM IST Arihant Capital has come out with its report on Rolex Rings. The research firm has recommended to ''Subscribe'' the ipo in its research report as on July 27, 2021.
July 28, 2021 12:23 PM IST KR Choksey has come out with its report on Rolex Rings. The research firm has recommended to ''Subscribe'' the ipo in its research report as on July 28, 2021.
July 28, 2021 11:42 AM IST Considering the business growth outlook and almost stable operating margins, Choice Broking assigned a 'subscribe' rating to the issue.
July 28, 2021 11:27 AM IST Rolex Rings IPO: At the upper band of IPO price of Rs 900, it is valued at a P/E multiple of 35 (on recalculated EPS excluding the Rs 25 crore deferred tax credit) which is lower than the industry average of 83, said KR Choksey Research.
July 28, 2021 08:57 AM IST Rolex Rings IPO: At higher price band of Rs 900, Rolex Rings is demanding a price-to-earnings (P/E) valuation of 28.2x (to its restated FY21 EPS of Rs 31.9) with a market cap of Rs 2,451 crore, while its peers namely Ramkrishna Forgings and MM Forgings are trading at a P/E of 123.30 and 37.14, respectively
July 27, 2021 08:21 PM IST Marquee investors participated in the anchor book were Invesco Mutual Fund, Matthews Asia Funds, and HSBC Global Investment Funds.
July 27, 2021 03:45 PM IST The public issue will be open for subscription between July 28-30.
July 27, 2021 01:43 PM IST Geojit has come out with its report on Glenmark Life Sciences. The research firm has recommended to ''Subscribe'' the ipo in its research report as on July 24, 2021.
July 27, 2021 01:38 PM IST Ajcon Global has come out with its report on Glenmark Life Sciences. The research firm has recommended to ''Subscribe'' the ipo in its research report as on July 26, 2021.
July 27, 2021 01:30 PM IST Arihant Capital has come out with its report on Glenmark Life Sciences. The research firm has recommended to ''Subscribe'' the ipo in its research report as on July 26, 2021.
July 27, 2021 01:24 PM IST Choice Equity Broking has come out with its report on Glenmark Life Sciences. The research firm has recommended to ''Subscribe'' the ipo in its research report as on July 23, 2021.
July 27, 2021 11:27 AM IST The subsidiary of Glenmark Pharma plans to raise Rs 1,513.6 crore through the public issue which comprises a fresh issue of Rs 1,060 crore, and an offer for sale of 63 lakh equity shares by promoter.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
